학술논문
Neoadjuvant trastuzumab plus pertuzumab in HER2 positive breast cancer in a country with limited resources: Evaluation of complete pathological response in a real world practice.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755